Mammary hamartoma

Ruiz Tovar, J; Reguero Callejas, M. E; Aláez Chillarón, A. B; Ramiro Pérez, C; Collado Guirao, M. V; Rojo Blanco, R; Muñoz Martín-Cámara, J; González-Palacios, F; García Villanueva, A.
Clin. transl. oncol. (Print) ; 8(4): 290-293, abr. 2006. ilus
Artículo en En | IBECS (España) | ID: ibc-047670

Documentos relacionados

  1. Mammary stromal-epithelial lesions with myofibroblastic stroma and HMGA2 overexpression linked smooth muscle differentiation, a case series from single institution.
  2. Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study.
  3. The First Case of HER2+ Invasive Ductal Carcinoma Arising From a Breast Hamartoma and Literature Review.
  4. A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment.
  5. Tumor volume doubling time estimated from digital breast tomosynthesis mammograms distinguishes invasive breast cancers from benign lesions.
  6. Mammographic calcifications undergoing percutaneous biopsy: outcome in women with and without a personal history of breast cancer.
  7. Changing clinical picture of mammary hamartoma.
  8. CT values of contrast-enhanced CBBCT: A useful diagnostic tool for benign and malignant breast lesions.
  9. US and Digital Breast Tomosynthesis in Women with Focal Breast Complaints: Results of the Breast US Trial (BUST).
  10. Adenolipoma of the breast.